News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioTrends Announces Newly Expanded Oncology Division to Focus on Launch Metrics of Bristol-Myers Squibb Company (BMY)'s Yervoy, Roche (RHHBY) and Daiichi Sankyo, Inc. (D4S.F)'s Zelboraf, Pfizer Inc. (PFE)'s Xalkori and Johnson & Johnson (JNJ)'s Zytiga


9/15/2011 9:46:36 AM

EXTON, Pa.--(BUSINESS WIRE)--The Oncology marketplace is going through a paradigm shift with new product launches and competitive promotion vying for patient treatment share. These new marketing reports written by Oncology experts will provide essential insights into the market dynamics.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES